Incident hepatitis C virus infection in a community-based population in Japan

Journal of Viral Hepatitis

Volumn 9, Issue 1, 2002, Pages 43-51

  Okayama, Akihiko ^a   Stuver, S O ^b   Tabor, E ^c   Tachibana, N ^a   Kohara, M ^d   Mueller, N E ^b   Tsubouchi, H ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Cohort study; Hepatitis C virus; Incidence; Sero epidemiologic methods

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; VIRUS RNA;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RATE; JAPAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEROCONVERSION;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; COHORT STUDIES; COMMUNITY HEALTH SERVICES; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RNA, VIRAL; VIRAL CORE PROTEINS;

EID: 0036902344     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2002.00331.x     Document Type: Article

References (37)

1. Okuda K. Hepatitis C virus and hepatocellular carcinoma. In: Okuda K, Tabor E, eds. Liver Cancer. New York: Churchill Livingstone, 1997: 39-50.
2. Watanabe J, Minegishi K, Mitsumori T et al. Prevalence of anti-HCV antibody in blood donors in the Tokyo area. Vox Sang 1990; 59: 86-88.
3. Tanaka H, Hiyama T, Tsukuma H et al. Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan. Cancer Causes Control 1994; 5: 409-413.
4. Yamaguchi K, Kiyokawa H, Machida J et al. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients. FEMS Microbiol Rev 1994; 14: 253-258.
5. Setoguchi Y, Yamamoto K, Ozaki I et al. Prevalence of chronic liver diseases and anti-HCV antibodies in different districts of Saga, Japan. Gastroenterol Jpn 1991; 26: 157-161.
6. Hayashi J, Kishihara Y, Yamaji K et al. Transmission of hepatitis C virus by health care workers in a rural area of Japan. Am J Gastroenterol 1995; 90: 794-799.
7. Nakashima K, Ikematsu H, Hayashi J, Kishihara Y, Mitsutake A, Kashiwagi S. Intrafamilial transmission of hepatitis C virus among the population of an endemic area of Japan. JAMA 1995; 274: 1459-1461.
8. Kiyosawa K, Tanaka E, Sodeyama T et al. Transmission of hepatitis C in an isolated area in Japan: Community-acquired infection. Gastroenterology 1994; 106: 1596-1602.
9. Sasaki F, Tanaka J, Moriya T et al. Very low incidence rates of community-acquired hepatitis C virus infection in company employees, long-term inpatients, and blood donors in Japan. J Epidemiol 1996; 6: 198-203.
10. Alter HJ. To C or not to C: These are the questions. Blood 1995; 85: 1681-1695.
11. Hoofnagle JH, Hepatitis C. The clinical spectrum of disease. Hepatology 1997; 26 (suppl 1): 15S-20S.
12. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-675.
13. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993; 88: 240-243.
14. Tanaka K, Hirohata T, Koga S et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991; 51: 2842-2847.
15. Alter MJ, Margolis HS, Krawczynski K et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 27: 1899-1905.
16. Tanaka K, Stuver SO, Ikematsu H et al. Heterosexual transmission of hepatitis C virus among married couples in southwestern Japan. Int J Cancer 1997; 72: 50-55.
17. Boschi-Pinto C, Stuver S, Okayama A et al. A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan. J Infect Dis 2000; 181: 35-41.
18. Mueller N, Okayama A, Stuver S, Tachibana N. Findings from the Miyazaki Cohort Study. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13 (suppl 1): S2-S7.
19. Kashiwakuma T, Hasegawa A, Kajita T et al. Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA). J Immunol Methods 1996; 190: 78-79.
20. Tanaka T, Lau JYN, Mizokami M et al. Simple fluorescent EIA for detection and quantification of hepatitis C viremia. J Hepatol 1995; 23: 742-745.
21. Stuver SO, Okayama A, Tachibana N, Tsubouchi H, Mueller NE, Tabor ETHCV. Infection and liver cancer mortality in a Japanese population with HTLV-I. Int J Cancer 1996; 67: 35-37.
22. Fukuizumi K, Sata M, Suzuki H, Nakano H, Tanikawa K. Hepatitis C virus seroconversion rate in a hyperendemic area of HCV in Japan: A prospective study. Scan J Infect Dis 1997; 29: 345-347.
23. Shimoyama R, Kato T, Sekiguchi S. Anti-hepatitis C virus seroconversion in blood donors in Japan (letter). Transfusion 1997; 37: 564-565.
24. Ito S-I, Ito M, Cho M-J, Shimotohno K, Tajima K. Massive sero-epidemiologic survey of hepatitis C virus: Clustering of carriers on the southwest coast of Tsushima, Japan. Jpn J Cancer Res 1991; 82: 1-3.
25. Noguchi S, Sata M, Suzuki H, Mizokami M, Tanikawa K. Routes of transmission of hepatitis C virus in an endemic rural area of Japan. Molecular epidemiologic study of hepatitis C virus infection. Scand J Infect Dis 1997; 29: 23-28.
26. Stuver SO, Tanaka K, Ikematsu H et al. Heterosexual transmission of hepatitis C virus among married couples in southwestern Japan [letter]. Int J Cancer 2000; 88: 833-834.
27. Alberti A, Chemello L, Benvegnù L. Natural history of hepatitis C. J Hepatol 1999; 31 (suppl 1): 17-24.
28. Marcellin P, Hepatitis C. The clinical spectrum of disease. J Hepatol 1999; 31 (suppl 1): 9-16.
29. Tawaraya H, Ohkoshi S, Kuwana K, Watanabe M, Kamimura T, Asakura H. Epidemiologic survey and genetic analysis of endemic hepatitis C virus infection in a Japanese town with a high prevalence of hepatitis B virus carriers. J Med Virol 1995; 45: 367-372.
30. Ishibashi M, Shinzawa H, Kuboki M, Tsuchida H, Takahashi T. Prevalence of inhabitants with anti-hepatitis C virus antibody in an area following an acute hepatitis C epidemic: Age- and area-related features. J Epidemiol 1996; 6: 1-7.
31. Alter HJ, Contry-Catilena C, Melpolder J et al. Hepatitis C in asymptomatic blood donors. Hepatology 1997; 26 (suppl 1): 29S-33S.
32. Alter MJ, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-562.
33. Kenny-Walsh E for the Irish Hepatology Research Group. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J Med 1999; 340: 1228-1233.
34. Wiese M, Berr F, Lafrenz M, Porst H, Oesen U for the East German Hepatitis C Study Group. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: A 20-year multicenter study. Hepatology 2000; 32: 91-96.
35. Alonso C, Pedroso ML, de Sanjosé S et al. Hepatitis C virus among blood donors: Follow-up study. Transfusion 1994; 34: 527-530.
36. Kuboki M, Shinzawa H, Shao L et al. A cohort study of hepatitis C virus (HCV) infection in an HCV epidemic area of Japan: Age and sex-related seroprevalence of anti HCV antibody, frequency of viremia, biochemical abnormality and histological changes. Liver 1999; 19: 88-96.
37. Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-1466.